We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

5 hedge funds and large institutions have $6.3M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

40% less capital invested

Capital invested by funds: $10.4M → $6.3M (-$4.13M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$11.4K
2
SFM
Sphera Funds Management
Israel
-$6.82K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$2.77M – – –
NMC
2
NEA Management Company
Maryland
$2.64M – – –
SFM
3
Sphera Funds Management
Israel
$523K -$6.82K -120 -1%
PF
4
Phoenix Financial
Israel
$282K +$398K +7,000 New
Millennium Management
5
Millennium Management
New York
$78K -$11.4K -200 -10%

PHXM Hedge Fund Activity: Q3 2019 in Review

5 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q3 2019, worth a combined $6.3M — down 40% from $10.4M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PHXM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest seller was Millennium Management, cutting an estimated $11.4K.

  • 5 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $6.3M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q3 2019, down 40% quarter-over-quarter.
  • 1 fund opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q3 2019 and 0 closed out, a net change of +1 holder.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q3 2019 was Millennium Management, an estimated $11.4K sold.

Based on aggregated 13F filings for Q3 2019.